These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 22371916)
1. Nitric oxide and antioxidant status in head and neck carcinoma before and after radiotherapy. Dahiya K; Dhankhar R; Madaan H; Singh V; Arora K Ann Clin Lab Sci; 2012; 42(1):94-7. PubMed ID: 22371916 [TBL] [Abstract][Full Text] [Related]
2. Pre-radiotherapy plasma carotenoids and markers of oxidative stress are associated with survival in head and neck squamous cell carcinoma patients: a prospective study. Sakhi AK; Russnes KM; Thoresen M; Bastani NE; Karlsen A; Smeland S; Blomhoff R BMC Cancer; 2009 Dec; 9():458. PubMed ID: 20025747 [TBL] [Abstract][Full Text] [Related]
3. Enhanced lipid peroxidation and nitric oxide products with deranged antioxidant status in patients with head and neck squamous cell carcinoma. Rasheed MH; Beevi SS; Geetha A Oral Oncol; 2007 Apr; 43(4):333-8. PubMed ID: 16857409 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of serum levels of oxidized and reduced glutathione and total antioxidant capacity in patients with head and neck squamous cell carcinoma. Pakfetrat A; Dalirsani Z; Hashemy SI; Ghazi A; Mostaan LV; Anvari K; Pour AM J Cancer Res Ther; 2018; 14(2):428-431. PubMed ID: 29516932 [TBL] [Abstract][Full Text] [Related]
5. Post-radiotherapy plasma total glutathione is associated to outcome in patients with head and neck squamous cell carcinoma. Bøhn SK; Smeland S; Sakhi AK; Thoresen M; Russnes KM; Tausjø J; Svilaas A; Svilaas T; Blomhoff R Cancer Lett; 2006 Jul; 238(2):240-7. PubMed ID: 16157445 [TBL] [Abstract][Full Text] [Related]
6. Serum nitric oxide levels in patients with head and neck squamous cell carcinoma. Kizilay A; Kalcioğlu MT; Ozuğurlu F; Ozyurt H; Aladağ I; Ozturan O; Akyol O Kulak Burun Bogaz Ihtis Derg; 2007; 17(3):148-51. PubMed ID: 17873505 [TBL] [Abstract][Full Text] [Related]
7. Alleviation of oxidative and nitrosative stress following curative resection in patient with oral cavity cancer. Rasheed MH; Beevi SS; Rajaraman R; Bose SJ J Surg Oncol; 2007 Sep; 96(3):194-9. PubMed ID: 17443722 [TBL] [Abstract][Full Text] [Related]
8. Pretreatment albumin level predicts survival in head and neck squamous cell carcinoma. Lim WS; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY Laryngoscope; 2017 Dec; 127(12):E437-E442. PubMed ID: 28561532 [TBL] [Abstract][Full Text] [Related]
9. DNA damage and oxidant-antioxidant status in blood of patients with head and neck cancer. Milonski J; Zielinska-Blizniewska H; Olszewski J; Majsterek I; Mrowicka M DNA Cell Biol; 2015 Mar; 34(3):213-9. PubMed ID: 25489965 [TBL] [Abstract][Full Text] [Related]
10. Pre-therapeutic fibrinogen levels are of prognostic significance in locally advanced head and neck cancer. Selzer E; Grah A; Heiduschka G; Kornek G; Thurnher D Wien Klin Wochenschr; 2016 May; 128(9-10):320-8. PubMed ID: 26919854 [TBL] [Abstract][Full Text] [Related]
11. An investigation of oxidative stress and coenzyme Q10 levels in patients with head and neck squamous cell carcinomas. Aksoy A; Kurnaz SÇ Eur Arch Otorhinolaryngol; 2019 Apr; 276(4):1197-1204. PubMed ID: 30729295 [TBL] [Abstract][Full Text] [Related]
12. Evidence of oxidative and nitrosative stress in patients with cervical squamous cell carcinoma. Beevi SS; Rasheed MH; Geetha A Clin Chim Acta; 2007 Jan; 375(1-2):119-23. PubMed ID: 16889762 [TBL] [Abstract][Full Text] [Related]
13. The prognostic value of pretreatment platelet count in patients with head and neck squamous cell carcinoma. Pardo L; Valero C; López M; García J; Camacho M; Quer M; León X Auris Nasus Larynx; 2017 Jun; 44(3):313-318. PubMed ID: 27401121 [TBL] [Abstract][Full Text] [Related]
14. Effect of smoking on oxygen delivery and outcome in patients treated with radiotherapy for head and neck squamous cell carcinoma--a prospective study. Hoff CM; Grau C; Overgaard J Radiother Oncol; 2012 Apr; 103(1):38-44. PubMed ID: 22385797 [TBL] [Abstract][Full Text] [Related]
15. Head and neck squamous cell carcinoma as a model of oxidative-stress and cancer. Bentz B J Surg Oncol; 2007 Sep; 96(3):190-1. PubMed ID: 17443719 [No Abstract] [Full Text] [Related]
16. Trace metals and total antioxidant potential in head and neck cancer patients. Akinmoladun VI; Owotade FJ; Olusanya AA Ann Afr Med; 2013; 12(2):131-4. PubMed ID: 23713022 [TBL] [Abstract][Full Text] [Related]
17. Glutathione, ascorbic acid and antioxidant enzymes in the tumor tissue and blood of patients with oral squamous cell carcinoma. Fiaschi AI; Cozzolino A; Ruggiero G; Giorgi G Eur Rev Med Pharmacol Sci; 2005; 9(6):361-7. PubMed ID: 16479741 [TBL] [Abstract][Full Text] [Related]
18. IAEA-HypoX. A randomized multicenter study of the hypoxic radiosensitizer nimorazole concomitant with accelerated radiotherapy in head and neck squamous cell carcinoma. Hassan Metwally MA; Ali R; Kuddu M; Shouman T; Strojan P; Iqbal K; Prasad R; Grau C; Overgaard J Radiother Oncol; 2015 Jul; 116(1):15-20. PubMed ID: 25913070 [TBL] [Abstract][Full Text] [Related]
19. Prostacyclin-synthase expression in head and neck carcinoma patients and its prognostic value in the response to radiotherapy. Camacho M; Piñeiro Z; Alcolea S; García J; Balart J; Terra X; Avilés-Jurado FX; Soler M; Quer M; León X; Vila L J Pathol; 2015 Jan; 235(1):125-35. PubMed ID: 25256272 [TBL] [Abstract][Full Text] [Related]
20. Assessment of the redox profile and oxidative DNA damage (8-OHdG) in squamous cell carcinoma of head and neck. Kumar A; Pant MC; Singh HS; Khandelwal S J Cancer Res Ther; 2012; 8(2):254-9. PubMed ID: 22842371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]